A Randomized, Phase 2 Study of 24-h Efficacy and Tolerability of Netarsudil in Ocular Hypertension and Open-Angle Glaucoma

INTRODUCTION: Pharmacotherapy to lower intraocular pressure (IOP) is a mainstay of treatment aimed at delaying progression of visual field loss in ocular hypertension (OHT) and open-angle glaucoma (OAG), but some topical treatments are less effective in controlling IOP at night. Peak IOP may be rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Peace, James H., McKee, Hayley J., Kopczynski, Casey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887148/
https://www.ncbi.nlm.nih.gov/pubmed/33244711
http://dx.doi.org/10.1007/s40123-020-00322-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887148/
https://www.ncbi.nlm.nih.gov/pubmed/33244711
http://dx.doi.org/10.1007/s40123-020-00322-1

Ejemplares similares